Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CCKBR | P32239 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5081959 | 0.90 | ATM (0.49) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5077577 | 0.90 | CYP3A4 (0.64) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5078272 | 0.85 | CYP3A4 (0.47) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5139117 | 0.84 | CYP3A4 (0.54) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL9419541 | 0.82 | CA2 (0.44) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5137409 | 0.82 | CYP3A4 (0.51) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5081506 | 0.81 | CYP3A4 (0.66) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL7789131 | 0.80 | CA2 (0.48) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL5138312 | 0.80 | TSHR (0.49) | CYP3A4TSHRTDP1ATMCA2 | |
| SCHEMBL16475 | 0.79 | CYP1A2 (0.44) | ALDH1A1LMNACYP1A2CCKBRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080319015-A1 | Insect Repellent Mixture | MERCK PATENT GESELLSCHAFT (DE) | 2008-12-25 | — | — | US | claimed |
| EP-1965639-A1 | INSECT REPELLENT MIXTURE | Merck Patent GmbH (DE) | 2008-09-10 | — | — | EP | claimed |
| WO-2007079822-A1 | INSECT REPELLENT MIXTURE | MERCK PATENT GMBH (DE) | 2007-07-19 | — | — | WO | claimed |
| US-20070141014-A1 | Formulation assistants | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2007-06-21 | — | — | US | claimed |
| EP-1725520-A2 | FORMULATION AUXILIARY AGENTS (AMINOPROPANOIC ACID DERIVATIVE) IN COSMETIC OR DERMATOLIGICAL PREPARATIONS | MERCK PATENT GmbH (DE) | 2006-11-29 | — | — | EP | claimed |
| WO-2005074897-A2 | FORMULATION AUXILIARY AGENTS (AMINOPROPANOIC ACID DERIVATIVE) IN COSMETIC OR DERMATOLOGICAL PREPARATIONS | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | WO | claimed |
| US-20080319015-A1 | Insect Repellent Mixture | MERCK PATENT GESELLSCHAFT (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1965639-A1 | INSECT REPELLENT MIXTURE | Merck Patent GmbH (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007079822-A1 | INSECT REPELLENT MIXTURE | MERCK PATENT GMBH (DE) | 2007-07-19 | — | — | WO | disclosed |
| US-20070141014-A1 | Formulation assistants | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2007-06-21 | — | — | US | disclosed |
| EP-1725520-A2 | FORMULATION AUXILIARY AGENTS (AMINOPROPANOIC ACID DERIVATIVE) IN COSMETIC OR DERMATOLIGICAL PREPARATIONS | MERCK PATENT GmbH (DE) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005074897-A2 | FORMULATION AUXILIARY AGENTS (AMINOPROPANOIC ACID DERIVATIVE) IN COSMETIC OR DERMATOLOGICAL PREPARATIONS | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070141014-A1 | Formulation assistants | C1S, C1R, AKR1C3 | CYP3A4 104/4885TSHR 2444/4885TDP1 4665/4885 |
| US-20080319015-A1 | Insect Repellent Mixture | DDT, BCHE, DNPH1 | CYP3A4 1141/4885TSHR 4143/4885TDP1 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.